Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

HEC Pharm presents FLT3 inhibitors

Jan. 29, 2016

Gruenenthal discloses phosphodiesterase 4B inhibitors

Jan. 29, 2016

University of Texas System patents mitochondrial GLS inhibitors

Jan. 28, 2016

Alpharmagen discloses nicotinic acetylcholine alpha7 modulators

Jan. 28, 2016

University of Texas System patents mitochondrial GLS1 inhibitors

Jan. 27, 2016

Novartis reports soluble guanylate cyclase activators

Jan. 26, 2016

Sunshine Lake Pharma discloses JAK3 inhibitors

Jan. 26, 2016

Polish institutions report 5-HT/dopamine receptor modulators

Jan. 26, 2016

Pharmacyclics reports BTK inhibitors

Jan. 25, 2016

ST Pharm presents tankyrase-1 inhibitors

Jan. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...